CURIA GLOBAL INC
- Unique Entity ID (UEI)
- ELCNZCS8GEA3
- Parent company
- ALBANY MOLECULAR RESEARCH INC. (UEI KECGGH9MU4C9)
- Registered address
- ALBANY, NY, district NY-20
- Other names on record
- ALBANY MOLECULAR RESEARCH INC.; ALBANY MOLECULAR RESEARCH INCORPORATED; ALBANY MOLECULAR RESEARCH, INC.; CURIA GLOBAL, INC.
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 17, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027
USAspending lists no contract dollars for this vendor in fiscal year 2027 yet.
Fiscal year 2026: $4,651,551.29
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | $4,586,551.29 |
| Department of Veterans Affairs | $65,000 |
| District where the work is done | Contract dollars |
|---|---|
| NY-20Paul Tonko | $3,293,717.71 |
| CA-37Sydney Kamlager-Dove | $992,330.78 |
| NY-26Timothy M. Kennedy | $300,502.80 |
| FL-15Laurel M. Lee | $65,000 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| 75N95020F00003MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN) | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $3,167,870.83 | Ends July 1, 2024 |
| 75N95023F00001KATRITCH- UNIVERSITY OF SOUTHERN CALIFORNIA DMFP FOR BPN-35269 - CURIA GLOBAL, INC. | Department of Health and Human ServicesNational Institutes of Health | LOS ANGELES, CA-37 | $2,451,018.78 | Ends September 12, 2029 |
| 75N98026F00001EXPLORATORY CHEMISTRY AND HIT-TO-LEAD CHEMISTRY OPTION. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2029. DAP-NCAP-00000137 | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $2,138,209.31 | Ends March 20, 2029 |
| 75N95020F00002CMC DEVELOPMENT OF (R)-VK4-116 DIHYDROCHLORIDE SALT | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $1,795,194.50 | Ends March 31, 2026 |
| 75N95019F00089ALBANY MOLECULAR RESEARCH INC - BOZIK BPN 25203 | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $1,771,110.56 | Ends September 12, 2024 |
| 75N95024P00615NON-GMP SYNTHESIS OF COMPOUNDS. POP: 9/19/24-9/18/25. | Department of Health and Human ServicesNational Institutes of Health | BUFFALO, NY-26 | $884,002.80 | Ends September 18, 2027 |
| 75N98026F00002EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137. | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $692,173.36 | Ends March 20, 2028 |
| 75N98026F00003EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137. | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $669,174.79 | Ends March 20, 2028 |
| 75N93020F00003NONCLINICAL SERVICES - SCALE-UP SYNTHESIS OF APX2039, A NOVEL GWT1 ENZYME INHIBITOR IN FUNGI | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $620,124.91 | Ends September 30, 2021 |
| HHSN27100001IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16) | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $273,064.87 | Ends January 14, 2025 |
| HHSN27100001IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $173,705 | Ends March 15, 2027 |
| 75N95024P00489CGMP MITRAGYNINE HCL SUPPLEMENTAL STABILITY & ANALYTICAL ACTIVITIES | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $96,200 | Ends September 8, 2027 |
| 75N98026P01289NINDS: MEDICINAL CHEMISTRY | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $72,000 | Ends August 13, 2027 |
| 75N95019F00088ALBANY MOLECULAR RESEARCH, INC: WAGNER UCSD-0776890 ICH STABILITY STUDY. DMFP. | Department of Health and Human ServicesNational Institutes of Health | ALBANY, NY-20 | $71,865.75 | Ends April 30, 2022 |
| 36C24826P1290SYNTHESIS OF NPC86 | Department of Veterans Affairs | TAMPA, FL-15 | $65,000 | Ends September 14, 2027 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
No subcontract is reported under this vendor’s largest awards.
Lobbying reports and campaign receipts that name this vendor
No lobbying report, organization page or FEC receipt in our saved records has this vendor’s name or its parent company’s name.
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.